Saponins ofPanax notoginseng: chemistry, cellular targets and therapeutic opportunities in cardiovascular diseases
- 20 February 2014
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 23 (4), 523-539
- https://doi.org/10.1517/13543784.2014.892582
Abstract
Introduction: Among the notable breakthroughs in the past two decades of research in natural drug discovery is the identification of saponins (saponins in Panax notoginseng, PNS) as the primary ingredient of Panax notoginseng, an iconic herbal medicine in East Asia. Increasing evidences suggest that PNS have versatile effects against a variety of cardiovascular diseases (CVDs), leading to four clinical trials completed and/or underway. There is a timely need to summarize our current understanding of these natural compounds. Areas covered: In this review, the authors summarize and critically appraise the latest literature (mainly since 2008), which study PNS as potential therapeutic agents against CVDs. Furthermore, they introduce the structures of major PNS types, analyze their cellular targets and associated signaling pathways and discuss the emerging opportunities for their clinical applications. A major focus here is on how these compounds affect the cardiovascular system via diverse mechanisms of action. Expert opinion: The authors believe that future research should head in two directions. The first direction taken should involve establishing a PNS compounds library to correlate their functions with structures; the second direction should be by integrating network pharmacology and pharmaceutical techniques in the future development of these natural compounds as new vascular medicine.Keywords
This publication has 100 references indexed in Scilit:
- Macrophages in the Pathogenesis of AtherosclerosisCell, 2011
- Liver X Receptors in Atherosclerosis and InflammationCirculation Research, 2011
- Association between change in plasma triglyceride levels and risk of stroke and carotid atherosclerosis: Systematic review and meta-regression analysisAtherosclerosis, 2010
- Activation of liver X receptor reduces global ischemic brain injury by reduction of nuclear factor-κBNeuroscience, 2010
- Simultaneous determination of three major bioactive saponins of Panax notoginseng using liquid chromatography-tandem mass spectrometry and a pharmacokinetic studyChinese Medicine, 2010
- Comparison of Plasminogen Activator Inhibitor-1, Tissue Type Plasminogen Activator Antigen, Fibrinogen, and D-Dimer Levels in Various Age Decades in Patients With Type 2 Diabetes Mellitus and Stable Coronary Artery Disease (from the BARI 2D Trial)The American Journal of Cardiology, 2010
- The LDL ReceptorArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Flower extract of Panax notoginseng attenuates lipopolysaccharide-induced inflammatory response via blocking of NF-κB signaling pathway in murine macrophagesJournal of Ethnopharmacology, 2009
- Toll-like receptor ligand-induced activation of murine DC2.4 cells is attenuated by Panax notoginsengJournal of Ethnopharmacology, 2008
- Inflammation in atherosclerosisNature, 2002